Based on several discussions at ZNZ Strategy Meetings, many neuroscientists are convinced that more could be done to advance the transfer of research results into society. More specifically, translational neuroscience involves bringing new inventions generated in the laboratory to the patient and to society, with the objective of improving human health. In 2025, we started a series of Translational Minisymposia on selected topics.
The general format of a translational minisymposium is simple: Interested clinicians, technology developers and basic scientists are invited to half-day workshops dedicated to specific topics in neuroscience. Participants give brief pitches including first ideas of future translational research followed by a brainstorming and matchmaking session. Subsequently, researchers have the opportunity to apply for ZNZ seed funding for pilot projects developed in the symposia. A proposal should be submitted jointly by a basic neuroscientist and a clinician.
The first minisymposia were held successfully on translational stroke (January) and (April) epilepsy research. A first pilot project by Candela Diaz-Canestro and Marco Bacigaluppi of the Center for Molecular Cardiology at UZH on “Beneficial effects of exercise on cognitive function: mechanisms and implications for the treatment of stroke” is supported by the ZNZ.
The next event is scheduled for 2 July 2025 on translational neurodegeneration research.
Main image: iStock, happy manager meeting with workers in printing factory. Businessman having a discussion with coworkers in printing plant.